Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis.
van den Ende T, Ter Veer E, Machiels M, Mali RMA, Abe Nijenhuis FA, de Waal L, Laarman M, Gisbertz SS, Hulshof MCCM, van Oijen MGH, van Laarhoven HWM. van den Ende T, et al. Among authors: van oijen mgh, van laarhoven hwm. Cancers (Basel). 2019 Jan 11;11(1):80. doi: 10.3390/cancers11010080. Cancers (Basel). 2019. PMID: 30641964 Free PMC article.
Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis.
van den Ende T, Ter Veer E, Mali RMA, van Berge Henegouwen MI, Hulshof MCCM, van Oijen MGH, van Laarhoven HWM. van den Ende T, et al. Among authors: van oijen mgh, van laarhoven hwm, van berge henegouwen mi. Cancers (Basel). 2019 Apr 12;11(4):530. doi: 10.3390/cancers11040530. Cancers (Basel). 2019. PMID: 31013858 Free PMC article.
COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis.
van den Ende T, Abe Nijenhuis FA, van den Boorn HG, Ter Veer E, Hulshof MCCM, Gisbertz SS, van Oijen MGH, van Laarhoven HWM. van den Ende T, et al. Among authors: van oijen mgh, van den boorn hg, van laarhoven hwm. Front Oncol. 2019 Jul 25;9:684. doi: 10.3389/fonc.2019.00684. eCollection 2019. Front Oncol. 2019. PMID: 31403035 Free PMC article.
Gastro-oesophageal junction: to FLOT or to CROSS?
van den Ende T, Hulshof MCCM, van Berge Henegouwen MI, van Oijen MGH, van Laarhoven HWM. van den Ende T, et al. Among authors: van oijen mgh, van laarhoven hwm, van berge henegouwen mi. Acta Oncol. 2020 Feb;59(2):233-236. doi: 10.1080/0284186X.2019.1698765. Epub 2019 Dec 9. Acta Oncol. 2020. PMID: 31813320 No abstract available.
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types.
van den Ende T, van den Boorn HG, Hoonhout NM, van Etten-Jamaludin FS, Meijer SL, Derks S, de Gruijl TD, Bijlsma MF, van Oijen MGH, van Laarhoven HWM. van den Ende T, et al. Among authors: van oijen mgh, van den boorn hg, van laarhoven hwm, van etten jamaludin fs. Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188386. doi: 10.1016/j.bbcan.2020.188386. Epub 2020 Jun 12. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32540465 Free article.
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).
van den Ende T, de Clercq NC, van Berge Henegouwen MI, Gisbertz SS, Geijsen ED, Verhoeven RHA, Meijer SL, Schokker S, Dings MPG, Bergman JJGHM, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Nieuwdorp M, de Gruijl TD, Soeratram TTD, Ylstra B, van Grieken NCT, Bijlsma MF, Hulshof MCCM, van Laarhoven HWM. van den Ende T, et al. Among authors: van hillegersberg r, van laarhoven hwm, van berge henegouwen mi, van grieken nct. Clin Cancer Res. 2021 Jun 15;27(12):3351-3359. doi: 10.1158/1078-0432.CCR-20-4443. Epub 2021 Jan 27. Clin Cancer Res. 2021. PMID: 33504550 Clinical Trial.
24 results